1. Spain Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Laboratorio Reig Jofre, S.A.

Laboratorio Reig Jofre, S.A.

RJF.MC
Laboratorio Reig Jofre, S.A.ES flagMadrid Stock Exchange
2.69
EUR
- -
- -
220.78MMarket Cap

Total Valuation

Laboratorio Reig Jofre, S.A. carries a market capitalization of 220.78M, placing it among publicly traded companies globally. Its enterprise value stands at 291.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap220.78M
Enterprise Value291.26M

Share Statistics

Laboratorio Reig Jofre, S.A. currently has 81.41M shares outstanding.

Shares Outstanding81.41M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Laboratorio Reig Jofre, S.A. trades at a trailing price-to-earnings ratio of 43.52. The price-to-sales ratio is 0.51, and the price-to-book ratio stands at 4.71.

PE Ratio43.52
PS Ratio0.51
PB Ratio4.71
P/TBV Ratio1.68
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Laboratorio Reig Jofre, S.A. trades at an EV/EBITDA multiple of 29.93 and an EV/FCF ratio of 320.58. The EV/Sales ratio of 0.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.93 provides insight into valuation relative to core operating earnings.

EV / Sales0.72
EV / EBITDA29.93
EV / EBIT29.93
EV / FCF320.58

Financial Position

Laboratorio Reig Jofre, S.A. maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.19, indicating elevated leverage, while an interest coverage ratio of 9.24 demonstrates adequate ability to service its debt obligations.

Current Ratio1.56
Quick Ratio0.20
Debt / Equity46.19
Debt / EBITDA10.61
Interest Coverage9.24

Financial Efficiency

Laboratorio Reig Jofre, S.A. posts a return on equity of 21.63 and a return on invested capital of 2.75.

Return on Equity (ROE)21.63
Return on Assets (ROA)1.24
Return on Invested Capital (ROIC)2.75
Return on Capital Employed (ROCE)5.49
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.27

Taxes

Over the trailing twelve months, Laboratorio Reig Jofre, S.A. has paid 757,000.00 in income taxes, reflecting an effective tax rate of 13.72.

Income Tax757,000.00
Effective Tax Rate13.72

Stock Price Statistics

Laboratorio Reig Jofre, S.A.'s stock has declined approximately -9.42761% over the past 52 weeks. The 50-day moving average sits at 2.71, while the 200-day moving average is 2.71.

Beta (5Y)N/A
52-Week Price Change-9.42761%
50-Day Moving Average2.71
200-Day Moving Average2.71
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Laboratorio Reig Jofre, S.A. generated 404.03M in revenue and converted that into 4.76M in net income, yielding earnings per share of 0.06. EBITDA reached 9.73M, while operating income came in at 9.73M.

Revenue404.03M
Gross Profit244.79M
Operating Income9.73M
Pretax Income5.52M
Net Income4.76M
EBITDA9.73M
EBIT9.73M
Earnings Per Share (EPS)0.06

Balance Sheet

Laboratorio Reig Jofre, S.A. holds 21.58M in cash and equivalents against 103.27M in total debt, resulting in a net debt position of 67.44M. Total book value stands at 44.04M, with working capital of 60.46M providing operational flexibility.

Cash & Cash Equivalents21.58M
Total Debt103.27M
Net Debt67.44M
Equity (Book Value)44.04M
Book Value Per Share0.52
Working Capital60.46M

Margins

Laboratorio Reig Jofre, S.A. operates with a gross margin of 60.59, reflecting its pricing power and cost economics. The operating margin of 2.41 and net profit margin of 1.18 provide insight into operational efficiency.

Gross Margin60.59
Operating Margin2.41
Pretax Margin1.37
Profit Margin1.18
EBITDA Margin2.41

Stock Splits

Laboratorio Reig Jofre, S.A.'s most recent stock split took place on September 22, 2015 with a 20:1 split ratio.

Last Split Date9/22/2015
Split Ratio20:1

Scores

Laboratorio Reig Jofre, S.A. posts an Altman Z-Score of 2.29, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.29